Welcure Drugs & Pharmaceuticals Ltd

Welcure Drugs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Welcure Drugs & Pharmaceuticals Ltd

₹ 0.29 0.00%
09 Mar - close price
Company website BSE: 524661
About

Incorporated in 1992, Welcure Drugs and Pharmaceuticals Ltd is in the business of pharmaceutical and healthcare.[1]

Key Points

Business Overview:[1]
WDPL is engaged in the manufacture and
trade of a wide range of healthcare formulations.

Website BSE
  • Market Cap ₹ 35.8 Cr.
  • Current Price ₹ 0.29
  • High / Low ₹ 1.45 / 0.28
  • Stock P/E
  • Book Value ₹ 0.46
  • Dividend Yield 0.00 %
  • ROCE -12.3 %
  • ROE -24.8 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Stock is trading at 0.63 times its book value
  • Company's working capital requirements have reduced from 74.6 days to 45.4 days

Cons

  • Company has low interest coverage ratio.
  • Company has a low return on equity of -17.6% over last 3 years.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008
16.36 24.67 25.67
17.92 25.91 27.68
Operating Profit -1.56 -1.24 -2.01
OPM % -9.54% -5.03% -7.83%
0.59 1.14 1.08
Interest 0.36 0.24 0.53
Depreciation 0.48 0.43 0.43
Profit before tax -1.81 -0.77 -1.89
Tax % 4.42% 11.69% 2.12%
-1.89 -0.86 -1.93
EPS in Rs -0.13 -0.06 -0.13
Dividend Payout % 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 4%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -124%
Stock Price CAGR
10 Years: 3%
5 Years: 10%
3 Years: -9%
1 Year: -63%
Return on Equity
10 Years: %
5 Years: %
3 Years: -18%
Last Year: -25%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008
Equity Capital 12.11 12.11 12.12
Reserves -2.49 -3.36 -5.29
3.79 3.73 2.76
4.74 7.01 7.76
Total Liabilities 18.15 19.49 17.35
6.70 6.41 6.02
CWIP 0.00 0.00 0.00
Investments 0.38 0.38 0.28
11.07 12.70 11.05
Total Assets 18.15 19.49 17.35

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008
-1.66 0.39 1.29
-1.22 -0.14 0.08
2.97 -0.28 -1.43
Net Cash Flow 0.09 -0.03 -0.06

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008
Debtor Days 112.67 119.40 123.56
Inventory Days 75.70 28.81 12.58
Days Payable 0.00 0.00 0.00
Cash Conversion Cycle 188.37 148.20 136.14
Working Capital Days 110.21 68.35 45.36
ROCE % -4.09% -12.32%

Insights

In beta
Mar 2012Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Domestic Sales Volume (Recognized Orders)
INR Crore ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login

Shareholding Pattern

Numbers in percentages

26 Recently
Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
99.99% 100.00% 100.00% 99.99% 100.00% 100.00% 100.00% 100.00% 99.98% 99.99% 99.99% 100.00%
No. of Shareholders 29,01329,25129,59329,95731,53031,04530,21830,60532,36637,29876,95487,288

Documents

Announcements

Annual reports